In a report released today, Whit Mayo from SVB Securities maintained a Buy rating on HCA Healthcare (HCA – Research Report), with a price target of $240.00. The company’s shares closed last Friday at $202.03.
According to TipRanks.com, Mayo is a 5-star analyst with an average return of 9.0% and a 56.9% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group.
Currently, the analyst consensus on HCA Healthcare is a Strong Buy with an average price target of $227.89, which is an 8.5% upside from current levels. In a report issued on July 11, Raymond James also maintained a Buy rating on the stock with a $220.00 price target.
HCA Healthcare’s market cap is currently $59.7B and has a P/E ratio of 9.71.
Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HCA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1968, HCA Healthcare, Inc. is a healthcare services company, based in Tennessee. The company operates general and psychiatric hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It also offers a full range of services to accommodate medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Read More on HCA:
- Analysts Offer Insights on Financial Companies: American Express (AXP) and Regions Financial (RF)
- Know Why SoFi Stock Sports a Neutral Smart Score on TipRanks
- Kodiak Sciences (KOD) Gets a Buy Rating from Jefferies
- Jefferies Maintains Their Hold Rating on Twitter (TWTR)
- Jefferies Thinks Procore Technologies’ Stock is Going to Recover